Aquestive Therapeutics Receives Conditional FDA Acceptance of Anaphylm Proprietary Name for Lead Candidate AQST-109 (Epinephrine Sublingual Film)

Aquestive Therapeutics Receives Conditional FDA Acceptance of Anaphylm Proprietary Identify for Lead Candidate AQST-109 (Epinephrine Sublingual Movie)

WARREN, NJ, April 20, 2023 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST) (the Firm or Aquestive), a pharmaceutical firm that advances medicines to resolve affected person issues with present requirements of care and supply transformative merchandise to enhance their lives, at the moment introduced that the U.S. Meals and Drug Administration (FDA) has conditionally…

Read More